You are here

Gleevac

Will This Court Decision Be a Thorn in the Side of Novartis?

Wall St. Cheat Sheet

Mon, 04/1/13 - 10:39 am

Novartis Urged To Drop Gleevec Patent Case

Pharmalot

Thu, 02/23/12 - 10:38 am

The Cancer Trial Bristol and Roche Must Do Now

Forbes

Thu, 08/26/10 - 06:21 pm

Bristol-Myers Squibb

Novartis wins FDA nod for broader Tasigna use

Fierce Pharma

Fri, 06/18/10 - 11:48 am

SPRYCEL(R) (dasatinib) Demonstrates Superior Confirmed Complete Cytogenetic Response Rates Compared to Gleevec(R)* in Study of Adult Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase

BusinessWire

Sat, 06/5/10 - 12:24 pm

chronic myeloid leukemia

For Blockbuster Cancer Drugs, Approvals Are the Easy Part

Motley Fool

Tue, 02/16/10 - 03:27 pm

Novartis' Cancer Plan

Forbes

Tue, 12/8/09 - 11:10 am

Novartis' Tasigna Seen Succeeding Top Drug Gleevec

WSJ Online

Thu, 10/22/09 - 09:49 am

Novartis’ Gleevec Approved for Recurrence of Tumors

Bloomberg

Mon, 12/22/08 - 07:45 am